Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FTCH
1351
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $4.8M | ﹤0.01% |
794,148
+448,346
| +130% | +$2.16M |
|
|
BERY
1352
DELISTED
Berry Global Group, Inc.
BERY
| $4.78M | ﹤0.01% |
80,957
+1,579
| +2% | +$86.2K |
|
1353
Acadia Healthcare
ACHC
$2.94B
| $4.77M | ﹤0.01% |
59,841
+38,431
| +180% | +$2.78M |
|
1354
Essent Group
ESNT
$6.33B
| $4.76M | ﹤0.01% |
101,705
-9,228
| -8% | -$402K |
|
1355
Littelfuse
LFUS
$11.6B
| $4.74M | ﹤0.01% |
16,277
+12,067
| +287% | +$3.16M |
|
1356
Cytokinetics
CYTK
$10.4B
| $4.74M | ﹤0.01% |
145,346
-195,926
| -57% | -$7.25M |
|
1357
CareTrust REIT
CTRE
$9.74B
| $4.73M | ﹤0.01% |
238,414
+5,097
| +2% | +$99.5K |
|
1358
Toast
TOST
$19.9B
| $4.73M | ﹤0.01% |
209,585
+56,707
| +37% | +$1.13M |
|
|
MZTI
1359
The Marzetti Company
MZTI
$3.11B
| $4.72M | ﹤0.01% |
23,489
+1,622
| +7% | +$329K |
|
1360
Vistra
VST
$47.4B
| $4.71M | ﹤0.01% |
179,524
-72,941
| -29% | -$1.78M |
|
1361
Ultragenyx Pharmaceutical
RARE
$2.55B
| $4.71M | ﹤0.01% |
102,141
+10,474
| +11% | +$486K |
|
1362
PUT
Alibaba
BABA
$308B
| $4.71M | ﹤0.01% |
56,500
-999,200
| -95% | -$87.5M |
|
1363
Merit Medical Systems
MMSI
$5.31B
| $4.68M | ﹤0.01% |
55,990
-2,361
| -4% | -$192K |
|
|
VSXY
1364
Victoria's Secret
VSXY
$7.84B
| $4.68M | ﹤0.01% |
268,518
+33,470
| +14% | +$843K |
|
1365
Denali Therapeutics
DNLI
$3.94B
| $4.68M | ﹤0.01% |
158,462
-497,965
| -76% | -$14M |
|
1366
ACI Worldwide
ACIW
$5.46B
| $4.66M | ﹤0.01% |
201,172
-2,964
| -1% | -$71.7K |
|
1367
Thomson Reuters
TRI
$44.1B
| $4.66M | ﹤0.01% |
33,979
-13,444
| -28% | -$1.8M |
|
1368
Innoviz Technologies
INVZ
$111M
| $4.65M | ﹤0.01% |
1,638,624
+17,174
| +1% | +$47.4K |
|
1369
Fox Factory Holding Corp
FOXF
$886M
| $4.65M | ﹤0.01% |
42,865
+16,626
| +63% | +$1.7M |
|
1370
CVB Financial
CVBF
$3.99B
| $4.65M | ﹤0.01% |
349,941
+220,386
| +170% | +$3.04M |
|
1371
Applovin
APP
$116B
| $4.63M | ﹤0.01% |
180,031
+168,402
| +1,448% | +$3.48M |
|
1372
Terreno Realty
TRNO
$7.49B
| $4.63M | ﹤0.01% |
77,047
-23,047
| -23% | -$1.41M |
|
1373
Prothena Corp
PRTA
$458M
| $4.63M | ﹤0.01% |
67,812
+3,208
| +5% | +$207K |
|
1374
BHP
BHP
$230B
| $4.63M | ﹤0.01% |
77,533
+301
| +0.4% | +$17.9K |
|
|
AMED
1375
DELISTED
Amedisys
AMED
| $4.62M | ﹤0.01% |
50,491
+43,293
| +601% | +$3.55M |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.